Avid Bioservices, founded in 2002, is a contract development and manufacturing organization (CDMO) specializing in biologics. The company boasts over 30 years of expertise in the field, with world-class mammalian protein production facilities.
Avid Bioservices has produced more than 250 commercial batches and successfully launched five commercial products in over 90 countries. Their exceptional track record is highlighted by over a decade of flawless quality assurance, underlining their commitment to operational excellence and efficiency.
The company's unique value proposition lies in its ability to personalize processes at every stage, from early development to market launch, permanently positioning itself as a valuable partner and advocate for its clients.
While specific details regarding its headquarters and previous investments are not disclosed, the comprehensive experience and performance history of Avid Bioservices make it a noteworthy player in the CDMO space, worth consideration by investors seeking robust returns in the biologics sector.